These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 25104306)

  • 1. Epidemiology of invasive meningococcal disease in the Netherlands, 1960-2012: an analysis of national surveillance data.
    Bijlsma MW; Bekker V; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Lancet Infect Dis; 2014 Sep; 14(9):805-12. PubMed ID: 25104306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual report of the Australian Meningococcal Surveillance Programme, 2011.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2012 Sep; 36(3):E251-62. PubMed ID: 23186236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian Meningococcal Surveillance Programme annual report, 2015.
    Lahra MM; Enriquez RP;
    Commun Dis Intell Q Rep; 2016 Dec; 40(4):E503-E511. PubMed ID: 28043225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B
    Mulhall RM; Bennett D; Cunney R; Borrow R; Lucidarme J; Findlow J; Jolley KA; Bray J; Maiden MCJ; Moschioni M; Serino L; Stella M; Medini D
    mSphere; 2018 Aug; 3(4):. PubMed ID: 30135218
    [No Abstract]   [Full Text] [Related]  

  • 5. Predicted coverage by 4CMenB vaccine against invasive meningococcal disease cases in the Netherlands.
    Freudenburg-de Graaf W; Knol MJ; van der Ende A
    Vaccine; 2020 Nov; 38(49):7850-7857. PubMed ID: 33097311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Annual report of the Australian Meningococcal Surveillance Programme, 2003.
    Commun Dis Intell Q Rep; 2004; 28(2):194-206. PubMed ID: 15460956
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B
    Tsang RSW; Law DKS; De Paola R; Giuliani M; Stella M; Zhou J; Deng S; Boccadifuoco G; Giuliani MM; Serino L
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32132156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Annual report of the Australian Meningococcal Surveillance Programme, 2007.
    Tapsall J;
    Commun Dis Intell Q Rep; 2008 Sep; 32(3):299-307. PubMed ID: 19062765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Australian Meningococcal Surveillance Programme annual report, 2012.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E224-32. PubMed ID: 24890958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Australian Meningococcal Surveillance Programme annual report, 2014.
    Lahra MM; Enriquez RP
    Commun Dis Intell Q Rep; 2016 Jun; 40(2):E221-8. PubMed ID: 27522133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Annual report of the Australian Meningococcal Surveillance Programme, 2005.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2006; 30(2):211-21. PubMed ID: 16841503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Temporal associations between national outbreaks of meningococcal serogroup W and C disease in the Netherlands and England: an observational cohort study.
    Knol MJ; Hahné SJM; Lucidarme J; Campbell H; de Melker HE; Gray SJ; Borrow R; Ladhani SN; Ramsay ME; van der Ende A
    Lancet Public Health; 2017 Oct; 2(10):e473-e482. PubMed ID: 29253430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decade of herd protection after introduction of meningococcal serogroup C conjugate vaccination.
    Bijlsma MW; Brouwer MC; Spanjaard L; van de Beek D; van der Ende A
    Clin Infect Dis; 2014 Nov; 59(9):1216-21. PubMed ID: 25069869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in the Population Structure of Invasive Neisseria meningitidis in the United States After Quadrivalent Meningococcal Conjugate Vaccine Licensure.
    Wang X; Shutt KA; Vuong JT; Cohn A; MacNeil J; Schmink S; Plikaytis B; Messonnier NE; Harrison LH; Clark TA; Mayer LW
    J Infect Dis; 2015 Jun; 211(12):1887-94. PubMed ID: 25556253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual report of the Australian Meningococcal Surveillance Programme, 2004.
    Austarlian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2005; 29(2):150-9. PubMed ID: 16119763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent epidemiological changes in meningococcal disease may be due to the displacement of serogroup A by serogroup C in Hefei City, China.
    Ni JD; Jin YH; Dai B; Wang XP; Liu DQ; Chen X; Zheng Y; Ye DQ
    Postgrad Med J; 2008 Feb; 84(988):87-92. PubMed ID: 18322129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Annual report of the Australian Meningococcal Surveillance Programme, 2002.
    Australian Meningococcal Surveillance Programme
    Commun Dis Intell Q Rep; 2003; 27(2):196-208. PubMed ID: 12926735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual report of the Australian Meningococcal Surveillance Programme, 2000.
    Commun Dis Intell Q Rep; 2001 Aug; 25(3):113-21. PubMed ID: 11596711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of Canadian meningococcal serogroup B isolates and estimated coverage by an investigational meningococcal serogroup B vaccine (4CMenB).
    Bettinger JA; Scheifele DW; Halperin SA; Vaudry W; Findlow J; Borrow R; Medini D; Tsang R;
    Vaccine; 2013 Dec; 32(1):124-30. PubMed ID: 23588089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Annual report of the Australian Meningococcal Surveillance Programme, 2007--Amended.
    Tapsall J;
    Commun Dis Intell Q Rep; 2009 Mar; 33(1):1-9. PubMed ID: 19618762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.